The role of galectin-4 in physiology and diseases

Abstract

Galectin-4, a tandem repeat member of the β-galactoside- binding proteins, possesses two carbohydraterecognition domains (CRD) in a single peptide chain. This lectin is mostly expressed in epithelial cells of the intestinal tract and secreted to the extracellular. The two domains have 40% similarity in amino acid sequence, but distinctly binding to various ligands. Just because the two domains bind to different ligands simultaneously, galectin-4 can be a crosslinker and crucial regulator in a large number of biological processes. Recent evidence shows that galectin-4 plays an important role in lipid raft stabilization, protein apical trafficking, cell adhesion, wound healing, intestinal inflammation, tumor progression, etc. This article reviews the physiological and pathological features of galectin-4 and its important role in such processes.

Key words： galectin-4; lipid raft; crosslinker; intestinal inflammation; tumor progression

References

1 Agrawal A, Samols D, Kushner I (2003) Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter. Mol Immunol 40:373–380

2 Allocca M, Jovani M, Fiorino G, Schreiber S, Danese S (2013) Anti-IL-6 treatment for inflammation bowel disease: next cytokine, next target. Curr Drug Target 12:1508–1521

3 Andersson M, Carlin N, Leontein K, Lindquist U, Slettengren K (1989) Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity. Carbohydr Res 185:211–223

4 Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 6:583–588

5 Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K (1994) Galectins: a family of animal pgalactoside-binding lectins. Cell 76:597–598

6 Barrow H, Guo X, Wandall HH, Pedersen JW, Fu B, Zhao Q, Chen C, Rhodes JM, Yu LG (2011) Serum galectin-2, -4, and-8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin Cancer Res 17:7035–7046

7 Barrow H, Rhodes JM, Yu LG (2013) Simultaneous determination of serum galectin-3 and-4 levels detects metastases in colorectal cancer patients. Cell Oncol 36:9–13

8 Belo AI, van der Sar AM, Tefsen B, van Die I (2013) Galectin-4 reduces migration and metastasis formation of pancreatic cancer cells. PLoS One 8:e65957

9 Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, Stevens J (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 101:17033–17038

10 Brewer FC (2002) Binding and cross-linking properties of galectins. Biochim Biophys Acta 1572:255–262

11 Brewer CF, Miceli MC, Baum LG (2002) Clusters, bundles, arrays and lattices: novel mechanisms for lectin–saccharide-mediated cellular interactions. Curr Opin Struct Biol 12:616–623

12 Bum-Erdene K, Leffler H, Nilsson UJ, Blanchard H (2015) Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigens. FEBS J 282:3348–3367

13 Cai Z, Zeng Y, Xu B, Gao Y, Wang S, Zeng J, Chen L, Huang A, Liu XL, Liu JF (2014) Galectin-4 serves as a prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinoma. Cancer Sci 105:1510–1517

14 Chen C, Duckworth CA, Fu B, Pritchard DM, Rhodes JM, Yu LG (2014) Circulating galectins-2, -4 and-8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis. Br J Cancer 110:741–752

15 Cheng L, Lemmon V (2004) Pathological missense mutations of neural cell adhesion molecule L1 affect neurite outgrowth and branching on an L1 substrate. Mol Cell Neurosci 27:522–530

16 Cheng L, Itoh K, Lemmon V (2005) L1-mediated branching is regulated by two ezrin–radixin–moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region. J Neurosci 25:395–403

17 Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin JA (2000) Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19:1123–1131

18 Cooper DN (2002) Galectinomics: finding themes in complexity. Biochim Biophys Acta 1572:209–231

19 Cooper DN, Barondes SH (1999) God must love galectins; he made so many of them. Glycobiology 9:979–984

20 Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta 1572:285–293

21 Danielsen EM, Hansen GH (2008) Lipid raft organization and function in the small intestinal brush border. J Physiol Biochem 64:377–382

22 Danielsen EM, van Deurs B (1997) Galectin-4 and small intestinal brush border enzymes form clusters. Mol Biol Cell 8:2241–2251

23 Delacour D, Gouyer V, Zanetta JP, Drobecq H, Leteurtre E, Grard G, Moreau-Hannedouche O, Maes E, Pons A, Andre S (2005) Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J Cell Biol 169:491–501

24 Dignass AU (2001) Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7:68–77

25 Gitt MA, Xia YR, Atchison RE, Lusis AJ, Barondes SH, Leffler H (1998) Sequence, structure, and chromosomal mapping of the mouse Lgals6 gene, encoding galectin-6. J Biol Chem 273:2961–2970

26 Hayashi T, Saito T, Fujimura T, Hara K, Takamochi K, Mitani K, Mineki R, Kazuno S, Oh S, Ueno T (2013) Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma. PLoS One 8:e81883

27 Helwa R (2010) Functional studies on the galectin-4 promoter and its use for establishing a transcription factors array assay. Dissertation, Ruperto-Carola University of Heidelberg, Heidelberg, pp 1–111

28 Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H (2001) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61:889–895

29 Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572:232–254

30 Hokama A, Mizoguchi E, Sugimoto K, Shimomura Y, Tanaka Y, Yoshida M, Rietdijk ST, de Jong YP, Snapper SB, Terhorst C (2004) Induced reactivity of intestinal CD4+ T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20:681–693

31 Hokama A, Mizoguchi E, Mizoguchi A (2008) Roles of galectins in inflammatory bowel disease. World J Gastroenterol 14:5133

32 Huflejt ME, Leffler H (2003) Galectin-4 in normal tissues and cancer. Glycoconj J 20:247–255

33 Huflejt ME, Jordan ET, Gitt MA, Barondes SH, Leffler H (1997) Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. Galectin-4 is localized at sites of cell adhesion. J Biol Chem 272:14294–14303

34 Ideo H, Seko A, Ohkura T, Matta KL, Yamashita K (2002) Highaffinity binding of recombinant human galectin-4 to SO3→3Galβ1→3GalNAc pyranoside. Glycobiology 12:199–208

35 Ideo H, Seko A, Yamashita K (2005) Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem 280:4730–4737

36 Ideo H, Seko A, Yamashita K (2007) Recognition mechanism of galectin-4 for cholesterol 3-sulfate. J Biol Chem 282:21081–21089

37 Ideo H, Hoshi I, Yamashita K, Sakamoto M (2013) Phosphorylation and externalization of galectin-4 is controlled by Src family kinases. Glycobiology 23:1452–1462

38 Jiang W, Puch S, Guo X, Bhavanandan VP (1999) Signature sequences for the galectin-4 subfamily. IUBMB Life 48:601–605

39 Kim SW, Park KC, Jeon SM, Ohn TB, Kim TI, Kim WH, Cheon JH (2013) Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer. Cell Oncol 36:169–178

40 Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M (1999) Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59:4990–4996

41 Lang SA, Moser C, Gaumann A, Klein D, Glockzin G, Popp FC, Dahlke MH, Piso P, Schlitt HJ, Geissler EK (2007) Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signaltransducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth. Clin Cancer Res 13:6459–6468

42 Leffler H, Masiarz FR, Barondes SH (1989) Soluble lactose-binding vertebrate lectins: a growing family. Biochemistry 28:9222–9229

43 Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Investig 84:553

44 Liu FT, Bevins CL (2010) A sweet target for innate immunity. Nat Med 16:263–264

45 London E, Brown DA (2000) Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508:182–195

46 Maftouh M, Belo AI, Avan A, Funel N, Peters GJ, Giovannetti E, van Die I (2014) Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signaling in pancreatic adenocarcinoma. Oncotarget 5:5335

47 Marková V, Smetana K, Jeníková G, Láchová J, Krejciríková V, Poplstein M, Fabry M, Brynda J, Alvarez RA, Cummings RD, Maly P (2006) Role of the carbohydrate recognition domains of mouse galectin-4 in oligosaccharide binding and epitope recognition and expression of galectin-4 and galectin-6 in mouse cells and tissues. Int J Mol Med 18:65–76

48 Mathieu A, Nagy N, Decaestecker C, Ferdinande L, Vandenbroucke K, Rottiers P, Cuvelier CA, Salmon I, Demetter P (2008) Expression of galectins-1, -3 and-4 varies with strain and type of experimental colitis in mice. Int J Exp Pathol 89:438–446

49 Matter K, Mellman I (1994) Mechamisms of cell polarity: sorting and transport in epithelial cells. Curr Opin Cell Biol 6:545–554

50 Mehrabian M, Gitt MA, Sparkes RS, Leffler H, Barondes SH, Lusis AJ (1993) Two members of the S-lac lectin gene family, LGALS1 and LGALS2, reside in close proximity on human chromosome 22q12-q13. Genomics 15:418–420

51 Morelle W, Stechly L, Andre S, Seuningen IV, Porchet N, Gabius HJ, Michalski JC, Huet G (2009) Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking. Biol Chem 390:529–544

52 Mostov KE, Verges M, Altschuler Y (2000)Membrane traffic in polarized epithelial cells. Curr Opin Cell Biol 12:483–490

53 Nagahama K, Ogawa A, Shirane K, Shimomura Y, Sugimoto K, Mizoguchi A (2008) Protein kinase C θ plays a fundamental role in different types of chronic colitis. Gastroenterology 134:459–469

54 Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468:244–252

55 Nishida A, Nagahama K, Imaeda H, Ogawa A, Lau CW, Kobayashi T, Hisamatsu T, Preffer FI, Mizoguchi E, Ikeuchi H (2012) Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells. J Exp Med 209:2383–2394

56 Oda Y, Herrmann J, Gitt MA, Turck CW, Burlingame AL, Barondes SH, Leffler H (1993) Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J Biol Chem 268:5929–5939

57 Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A (2008a) Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One 3:e2629

58 Paclik D, Lohse K, Wiedenmann B, Dignass AU, Sturm A (2008b) Galectin-2 and-4, but not Galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Inflamm Bowel Dis 14:1366–1372

59 Pike LJ (2005) Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim Biophys Acta 1746:260–273

60 Podolsky DK (1991) Inflammatory bowel disease. N Engl J Med 325:928–937

61 Rabinovich GA (1999) Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ 6:711–721

62 Rechreche H, Mallo GV, Montalto G, Dagorn JC, Iovanna JL (1997) Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer. Eur J Biochem 248:225–230

63 Rumilla KM, Erickson LA, Erickson AK, Lloyd RV (2006) Galectin-4 expression in carcinoid tumors. Endocr Pathol 17:243–249

64 Rustiguel JK, Kumagai PS, Dias-Baruffi M, Costa-Filho AJ, Nonato MC (2015) Recombinant expression, purification and preliminary biophysical and structural studies of C-terminal carbohydrate recognition domain from human galectin-4. Protein Expr Purif 118:39–48

65 Satelli A, Rao PS, Thirumala S, Rao US (2011) Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer 129:799–809

66 Schuck S, Simons K (2004) Polarized sorting in epithelial cells: raft clustering and the biogenesis of the apical membrane. J Cell Sci 117:5955–5964

67 Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Investig 110:597–603

68 Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE (1997) Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Investig 100:2952

69 Stancic M, Slijepcevic D, Nomden A, Vos MJ, De Jonge JC, Sikkema AH, Gabius HJ, Hoekstra D, Baron W (2012) Galectin-4, a novel neuronal regulator of myelination. Glia 60:919–935

70 Stechly L, Morelle W, Dessein AF, André S, Grard G, Trinel D, Dejonghe MJ, Leteurtre E, Drobecq H, Trugnan G (2009) Galectin-4-regulated delivery of glycoproteins to the brush border membrane of enterocyte-like cells. Traffic 10:438–450

71 Storan MJ, Magnaldo T, Biol-N’Garagba MC, Zick Y, Key B (2004) Expression and putative role of lactoseries carbohydrates present on NCAM in the rat primary olfactory pathway. J Comp Neurol 475:289–302

72 Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine JP, Heimburg-Molinaro J, Ju T, Molinaro RJ, Rivera-Marrero C, Xia B (2010) Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16:295–301

73 Tretiakova A, Steplewski A, Johnson EM, Khalili K, Amini S (1999) Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. J Cell Physiol 18:160–168

74 Velasco S, Díez-Revuelta N, Hernández-Iglesias T, Kaltner H, André S, Gabius HJ, Abad-Rodríguez J (2013) Neuronal Galectin-4 is required for axon growth and for the organization of axonal membrane L1 delivery and clustering. J Neurochem 125:49–62

75 Vokhmyanina OA, Rapoport EM, André S, Severov VV, Ryzhov I, Pazynina GV, Korchagina E, Gabius HJ, Bovin NV (2012) Comparative study of the glycan specificities of cell-bound human tandemrepeat-type galectin-4, -8 and-9. Glycobiology 22:1207–1217

76 Waldner MJ, Neurath MF (2014) Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Semin Immunol 1:75–79

77 Wei Q, Miskimins WK, Miskimins R (2003)TheSp1 family of transcription factors is involved in p27(Kip1)-mediated activation of myelin basic protein gene expression. Mol Cell Biol 23:4035–4045

78 Wei Q, Eviatar-Ribak T, Keith Miskimins W, Miskimins R (2007) Galectin-4 is involved in p27-mediated activation of the myelin basic protein promoter. J Neurochem 101:1214–1223

79 Wilson AJ, Gibson PR (1997) Epithelial migration in the colon: filling in the gaps. Clin Sci 93:97–108

80 Winzeler AM, Mandemakers WJ, Sun MZ, Stafford M, Phillips CT, Barres BA (2011) The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. J Neurosci 31:6481–6492

81 Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434

82 Yamamoto FI, Clausen H, White T, Marken J, Hakomori SI (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345:229–233

83 Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, Costa RH(1997) Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 17:1626–1641

84 Zhao Q, Guo X, Nash GB, Stone PC, Hilkens J, Rhodes JM, Yu LG (2009) Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res 69:6799–6806